Genesis Healthcare (GEN) – FDA
-
Genmab (GMAB) EPKINLY Approved by FDA as First and Only Bispecific Antibody to Treat Adults with R/R Diffuse Large B-cell Lymphoma
-
Genmab (GMAB) Announces That AbbVie (ABBV) Will Submit MAA to EMA for Epcoritamab for the Treatment of R/R DLBCL
-
-
-
-
-
-
-
-
-
-
Back to GEN Stock Lookup